Apoptosis

NCP26 TFA is an ATP-competitive ProRS inhibitor (with a K D of 271 nM in the absence of proline, and a K D of 0.35 nM in the presence of 100 μM proline).

OSU-2S TFA is a non-immunosuppressive derivative of Fingolimod hydrochloride (FTY720).

Temozolomide - 15 N (NSC 362856- 15 N) is the 15 N-labeled Temozolomide.

LLC355 is a discoidin domain receptor 1 ( DDR1 ) ATTEC degrader with a DC 50 of 150.8 nM.

A Bcl-2 inhibitor

An antimicrobial cationic peptide

An antagonist of calcitonin and amylin receptors

A perfluoroalkyl substance

A metabolite of various polyphenols

An inhibitor of microtubule polymerization

A glucosamine-based lipid conjugate

An inhibitor of PCNA

A microtubule destabilizer

A prodrug form of doxorubicin

NM-3 is a synthetic isocoumarin and an inhibitor of angiogenesis.

PDIC-NN is an intermediate in the synthesis of PDIC-NS , an activator of stimulator of interferon genes (STING) with anticancer activity.

PDIC-NS is an activator of stimulator of interferon genes (STING).

LMTK3 inhibitor C28 is a multi-kinase inhibitor.

TrkB agonist prodrug R13 (R13) is a prodrug form of the tropomyosin-related kinase B (TrkB) activator 7,8-dihydroxyflavone.

PTX80 is an antagonist of p62 (IC50 = 31.18 nM for the human receptor).

JQKD82 is a prodrug form of KDM5-C49, an inhibitor of Jumonji AT-rich interactive domain 1A (JARID1A), also known as lysine-specific demethylase 5A (KDM5A).

RMC-6236 is a reversible, GTP-binding RAS (ON) multi-selective inhibitor.

1,2,3-Trioleoyl glycerol-d5 is intended for use as an internal standard for the quantification of 1,2,3-trioleoyl glycerol by GC- or LC-MS.

MSG606 is a peptide antagonist of melanocortin receptor 1 (MC1R; IC50 = 17 nM for the human receptor) and a derivative of γ-melanocyte-stimulating hormone (γ-MSH).